T cell vaccination in systemic lupus erythematosus with autologous activated T cells

Lupus

Volumn 14, Issue 11, 2005, Pages 884-889

  Li, Zhan Guo ^a,c   Mu, R ^a   Dai, Z P ^b   Gao, X M ^b  

^a People's Hospital   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Systemic lupus erythematosus; T cell vaccine; Therapeutics

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLONING; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INOCULATION; LABORATORY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SAFETY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADOLESCENT; ADULT; ANTIBODY FORMATION; AUTOANTIBODIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; PILOT PROJECTS; REMISSION INDUCTION; T-LYMPHOCYTES; VACCINATION;

EID: 28444493670     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2239oa     Document Type: Article

References (36)

1. Mohan C, Adams S, Stanik V et al. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177: 1367-1381.
2. Kaliyaperumal A, Michaels MA, Datta SK. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. J Immunol 1999; 162: 5775-5783.
3. Pollard KM, Arnush M, Hultman P et al. Costimulation requirements of induced murine systemic autoimmune disease. J Immunol 2004; 173: 5880-5887.
4. Lu L, Kaliyaperumal A, Boumpas DT et al. Major peptide autoepitopes for nucleosome- specific T cells of human lupus. J Clin Inves 1999; 104: 345-355.
5. Talken BL, Holyst MM, Lee DR et al. T cell receptor beta-chain third complementarity- determining region gene usage is highly restricted among Sm-B autoantigen-specific human T cell clones derived from patients with connective tissue disease. Arthritis Rheum 1999; 42: 703-709.
6. Han SH, Li B, Chen YT et al. Isolation and functional analysis of autoreactive T cells from BXSB mice with murine lupus. J Autoimmun 2002; 19: 45-54.
7. Kyttaris VC, Tsokos GC. T lymphocytes in systemic lupus erythematosus: an update. Curr Opin Rheumatol 2004; 16: 548-552.
8. De Alboran IM, Gutierrez JC, Gonzalo JA et al. 1pr T cells vaccinate against lupus in MRL/1pr mice. Eur J Immunol 1992; 22: 1089-1093.
9. Ben-Yehuda A, Bar-Tana R, Livoff A et al. Lymph node cell vaccination against the lupus syndrome of MRL/1pr/1pr mice. Lupus 1996; 5: 232-236.
10. Zhang J, Medaer R, Stinissen P et al. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 1993; 261: 1451-1454.
11. Van der Aa A, Hellings N, Medaer R et al. T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study. Clin Exp Immunol 2003; 131: 155-168.
12. Achiron A, Lavie G, Kishner I et al. T cell vaccination in multiple sclerosis relapsing- remitting nonresponders patients. Clin Immunol 2004; 113: 155-160.
13. Zhang J, Vandevyver C, Stinissen P et al. In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination. J Immunol 1995; 155: 5868-5877.
14. Hermans G, Medaer R, Raus J et al. Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations. J Neuroimmunol 2000; 102: 79-84.
15. Liu X, Wang W, Lu Y et al. T cell vaccination induces regulatory humoral immune response in BALB/c mice. Chin J Immunol 2002; 18: 604-607.
16. Li B, Han S, Liu X et al. T cell vaccination against systemic lupus erythematosus in BXSB mice. Acad J Sec Military Med Uni 2002; 23: 1091-1094.
17. Zhang XY, Liu XG, Wang W et al. Anti-T-cell humoral and cellular responses in healthy BALB/c mice following immunization with ovalbumin or ovalbumin-specific T cells. Immunology 2003; 108: 465-473.
18. Elias D, Reshef T, Birk OS et al. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci USA 1991; 88: 3088-3091.
19. Smerdon RA, Peakman M, Hussain MJ et al. Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse. Immunology 1993; 80: 498-501.
20. Formby B, Shao T. T cell vaccination against autoimmune diabetes in nonobese diabetic mice. Ann Clin Lab Sci 1993; 23: 137-147.
21. Mor F, Lohse AW, Karin N et al. Clinical modeling of T cell vaccination against autoimmune diseases in rats. Selection of antigen-specific T cells using a mitogen. J Clin Invest 1990; 85: 1594-1598.
22. Lider O, Karin N, Shinitzky M et al. Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure. Proc Natl Acad Sci USA 1987; 84: 4577-4580.
23. Holoshitz J, Naparstek Y, Ben-Nun A et al. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983; 219: 56-58.
24. Chiocchia G, Boissier MC, Manoury B et al. T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen. Eur J Immunol 1993; 23: 327-332.
25. Kahn CR, McIntosh KR, Drachman DB. T-cell vaccination in experimental myasthenia gravis: a double-edged sword. J Autoimmun 1990; 3: 659-669.
26. Beraud E, Kotake S, Caspi RR et al. Control of experimental autoimmune uveoretinitis by low dose T cell vaccination. Cell Immunol 1992; 140: 112-122.
27. Dai ZP, Mu R, Li ZG et al. Generation and characterization of autoreactive T cell lines and clones from patients with SLE. Chin J Med 2003; 83: 696-697.
28. Singh RR, Kumar V, Ebling S et al. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J Exp Med 1995; 181: 2017-2027.
29. Adachi Y, Inaba M, Sugihara A et al. Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW × BXSB) F1 mice. Immunobiology 1998; 198: 451-464.
30. Mitsuhiro T, Hiroko N, Sakae K et al. Autoreactive T cell clones from patients with systemic lupus erythmatosus support polyclonal autoantibody production. J Immunol 1997; 158: 3529-3538.
31. Lohse AW, Bakker NP, Hermann E et al. Induction of an anti-vaccine response by T cell vaccination in non-human primates and humans. J Autoimmun 1993; 6: 121-130.
32. Hong J, Zang YC, Tejada-Simon MV et al. Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination. J Immunol 2000; 165: 6858-6864.
33. Weiner HL, Friedman A, Miller A et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12: 809-837.
34. Waisman A, Ruiz PJ, Hirschberg DL et al. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med 1996; 2: 899-905.
35. Zang YC, Hong J, Tejada-Simon MV et al. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis. Eur J Immunol 2000; 30: 908-913.
36. Desai-Mehta A, Lu LJ, Ramsey-Goldman R et al. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995; 95: 531-541.